Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
Open Access
- 6 November 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (11) , e7702
Abstract
Increased access to HIV testing is essential in working towards universal access to HIV prevention and treatment in resource-limited countries. We here evaluated currently used HIV diagnostic tests and algorithms in Cameroon for their ability to correctly identify HIV infections. We estimated sensitivity, specificity, and positive and negative predictive values of 5 rapid/simple tests, of which 3 were used by the national program, and 2 fourth generation ELISAs. The reference panel included 500 locally collected samples; 187 HIV -1 M, 10 HIV-1 O, 259 HIV negative and 44 HIV indeterminate plasmas. None of the 5 rapid assays and only 1 ELISA reached the current WHO/UNAIDS recommendations on performance of HIV tests of at least 99% sensitivity and 98% specificity. Overall, sensitivities ranged between 94.1% and 100%, while specificities were 88.0% to 98.8%. The combination of all assays generated up to 9% of samples with indeterminate HIV status, because they reacted discordantly with at least one of the different tests. Including HIV indeterminate samples in test efficiency calculations significantly decreased specificities to a range from 77.9% to 98.0%. Finally, two rapid assays failed to detect all HIV-1 group O variants tested, with one rapid test detecting only 2 out of 10 group O specimens. In the era of ART scaling-up in Africa, significant proportions of false positive but also false negative results are still observed with HIV screening tests commonly used in Africa, resulting in inadequate treatment and prevention strategies. Depending on tests or algorithms used, up to 6% of HIV-1 M and 80% of HIV-1 O infected patients in Cameroon do not receive ART and adequate counseling to prevent further transmission due to low sensitivities. Also, the use of tests with low specificities could imply inclusion of up to 12% HIV negative people in ART programs and increase budgets in addition to inconveniences caused to patients.Keywords
This publication has 23 references indexed in Scilit:
- The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic AlgorithmPLOS ONE, 2009
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 2009
- Unequal Detection of HIV Type 1 Group O Infection by Simple Rapid TestsClinical Infectious Diseases, 2008
- HIV-1 Subtype C Seronegative AIDSClinical Infectious Diseases, 2008
- A Seronegative Case of HIV-1 Subtype C Infection in BotswanaClinical Infectious Diseases, 2007
- Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant WomenJournal of Clinical Microbiology, 2004
- Synthetic Peptide Strategy for the Detection of and Discrimination among Highly Divergent Primate LentivirusesAIDS Research and Human Retroviruses, 2001
- HIV-1 Group O Infection in Cameroon, 1986 to 1998Emerging Infectious Diseases, 2001
- Detection of Diverse Variants of Human Immunodeficiency Virus–1 Groups M, N, and O and Simian Immunodeficiency Viruses from Chimpanzees by Using GenericpolandenvPrimer PairsThe Journal of Infectious Diseases, 2000
- HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patientsThe Lancet, 1994